SOPH logo

SOPHiA GENETICS SA (SOPH) Company Overview

Profile

Full Name:

SOPHiA GENETICS SA

Sector:

Healthcare

Country:

Switzerland

IPO:

July 23, 2021

Indexes:

Not included

Description:

SOPH (SOPHiA GENETICS SA) is a biotechnology company that uses data-driven medicine to improve patient care. They provide advanced genomic analysis tools to help doctors diagnose diseases and personalize treatments, making healthcare more effective and accessible for patients worldwide.

Key Details

Price

$3.95

Annual Revenue

$62.37 M(+31.14% YoY)

Annual EPS

-$1.22(+10.29% YoY)

Annual ROE

-44.93%

Beta

0.28

Events Calendar

Earnings

Next earnings date:

Mar 4, 2025

Recent quarterly earnings:

Nov 5, 2024

Recent annual earnings:

Mar 5, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Dec 18, 24 Craig-Hallum
Buy
Aug 7, 24 RBC Capital
Outperform
Jun 27, 24 Guggenheim
Buy
Mar 6, 24 RBC Capital
Outperform
Mar 6, 24 BTIG
Buy
Jan 12, 24 RBC Capital
Outperform
Nov 29, 23 RBC Capital
Outperform
May 10, 23 Morgan Stanley
Overweight
May 10, 23 Credit Suisse
Neutral
Mar 8, 23 Morgan Stanley
Overweight

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for SOPHiA GENETICS SA?
  • Does SOPHiA GENETICS SA pay dividends?
  • What sector is SOPHiA GENETICS SA in?
  • What industry is SOPHiA GENETICS SA in?
  • What country is SOPHiA GENETICS SA based in?
  • When did SOPHiA GENETICS SA go public?
  • Is SOPHiA GENETICS SA in the S&P 500?
  • Is SOPHiA GENETICS SA in the NASDAQ 100?
  • Is SOPHiA GENETICS SA in the Dow Jones?
  • When was SOPHiA GENETICS SA's last earnings report?
  • When does SOPHiA GENETICS SA report earnings?
  • Should I buy SOPHiA GENETICS SA stock now?

What is the ticker symbol for SOPHiA GENETICS SA?

The ticker symbol for SOPHiA GENETICS SA is NASDAQ:SOPH

Does SOPHiA GENETICS SA pay dividends?

No, SOPHiA GENETICS SA does not pay dividends

What sector is SOPHiA GENETICS SA in?

SOPHiA GENETICS SA is in the Healthcare sector

What industry is SOPHiA GENETICS SA in?

SOPHiA GENETICS SA is in the Health Information Services industry

What country is SOPHiA GENETICS SA based in?

SOPHiA GENETICS SA is headquartered in Switzerland

When did SOPHiA GENETICS SA go public?

SOPHiA GENETICS SA's initial public offering (IPO) was on July 23, 2021

Is SOPHiA GENETICS SA in the S&P 500?

No, SOPHiA GENETICS SA is not included in the S&P 500 index

Is SOPHiA GENETICS SA in the NASDAQ 100?

No, SOPHiA GENETICS SA is not included in the NASDAQ 100 index

Is SOPHiA GENETICS SA in the Dow Jones?

No, SOPHiA GENETICS SA is not included in the Dow Jones index

When was SOPHiA GENETICS SA's last earnings report?

SOPHiA GENETICS SA's most recent earnings report was on Nov 5, 2024

When does SOPHiA GENETICS SA report earnings?

The next expected earnings date for SOPHiA GENETICS SA is Mar 4, 2025

Should I buy SOPHiA GENETICS SA stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions